Home - Products - Others - Other Targets - Acacetin-7-O-3-Malonylglucoside

Acacetin-7-O-3-Malonylglucoside

CAS No. 1588563-85-2

Acacetin-7-O-3-Malonylglucoside( ——— )

Catalog No. M38392 CAS No. 1588563-85-2

Acacetin-7-O-(3-O-malonyl)-β-D-glucopyranoside (compound 13) is a compound that can be isolated from the moss Dicranum foetidum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Acacetin-7-O-3-Malonylglucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Acacetin-7-O-(3-O-malonyl)-β-D-glucopyranoside (compound 13) is a compound that can be isolated from the moss Dicranum foetidum.
  • Description
    Acacetin-7-O-(3-O-malonyl)-β-D-glucopyranoside (compound 13) is a compound that can be isolated from the moss Dicranum foetidum.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1588563-85-2
  • Formula Weight
    532.45
  • Molecular Formula
    C25H24O13
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Selenge E, et al. Monoterpene glycosides, phenylpropanoids, and acacetin glycosides from Dracocephalum foetidumJ. Phytochemistry, 2014, 101: 91-100.
molnova catalog
related products
  • DENV-IN-5

    Denv-in-5 is an effective and selective dengue virus (DENV) inhibitor with EC50 values of 1.47, 9.23, 7.08, 8.91 μM for denV-I-IV and 0.1512 μM for HIV-1IIIB.

  • Ponasterone A

    Ponasterone A is an analog of 20-hydroxy ecdysone.

  • RMC-7977

    RMC-7977 is a highly selective inhibitor of the active (GTP-bound) forms of KRAS, HRAS, and NRAS with anticancer activity for the study of solid tumors with KRAS G12C mutations.